Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Clin Endocrinol (Oxf). 2010 Jul;73(1):55–65. doi: 10.1111/j.1365-2265.2009.03742.x

Figure 2.

Figure 2

Age-adjusted prevalence of the metabolic syndrome (MetS) by number of dysregulated adipokines in the highest (leptin and resistin) and lowest for adiponectin tertile among non-obese and obese persons*.